Klaus Korn

5.7k total citations
107 papers, 2.4k citations indexed

About

Klaus Korn is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Klaus Korn has authored 107 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 41 papers in Virology and 40 papers in Epidemiology. Recurrent topics in Klaus Korn's work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (18 papers). Klaus Korn is often cited by papers focused on HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (18 papers). Klaus Korn collaborates with scholars based in Germany, United States and United Kingdom. Klaus Korn's co-authors include Bárbara Schmidt, Hauke Walter, Ulrike Kämmerer, Rolf Kaiser, Klaus Überla, Daniel Hoffmann, Niko Beerenwinkel, Joachim Selbig, Thomas Lengauer and Benedikt Weißbrich and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Klaus Korn

104 papers receiving 2.3k citations

Peers

Klaus Korn

VIROL

EPIDE

CCM

Wade Blair United States

Zehava Grossman Israel

Eleftherios Michailidis United States

Albrecht von Brunn Germany

Shingo Iwami Japan

John C. Tilton United States

Nir Paran Israel

Fei Yu China

Yasumasa Iwatani Japan

Noel A. Roberts United Kingdom

Wade Blair United States

Klaus Korn

1.1k ×0.8

1.1k ×1.3

VIROL

458 ×0.7

EPIDE

664 ×1.6

189 ×0.6

CCM

Citations per year, relative to Klaus Korn Klaus Korn (= 1×) peers Wade Blair

Countries citing papers authored by Klaus Korn

Since Specialization

Citations

This map shows the geographic impact of Klaus Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Korn more than expected).

Fields of papers citing papers by Klaus Korn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Korn. The network helps show where Klaus Korn may publish in the future.

Co-authorship network of co-authors of Klaus Korn

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Korn. A scholar is included among the top collaborators of Klaus Korn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Korn. Klaus Korn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herrmann, Alexandra, et al.. (2024). Molecular analysis of the 2022 mpox outbreak and antiviral activity of dihydroorotate dehydrogenase inhibitors against orthopoxviruses. Antiviral Research. 233. 106043–106043. 5 indexed citations

Cole, John, Klaus Korn, Amy R. Henry, et al.. (2024). Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection. Nature Communications. 15(1). 10200–10200. 3 indexed citations

Steininger, Philipp, Armin Ensser, Antje Knöll, & Klaus Korn. (2023). Results of Tick-Borne Encephalitis Virus (TBEV) Diagnostics in an Endemic Area in Southern Germany, 2007 to 2022. Viruses. 15(12). 2357–2357. 2 indexed citations

Bergmann, Silke, Philipp Steininger, Klaus Korn, et al.. (2023). Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller. Viruses. 15(2). 567–567.

Kremer, Andreas E., Carsten Willam, Simon Völkl, et al.. (2021). Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity. European Journal of Immunology. 51(10). 2478–2484. 4 indexed citations

Tödt, Daniel, Stephanie Pfaender, Thomas Bollinger, et al.. (2021). SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay. Clinical Microbiology and Infection. 27(9). 1353.e1–1353.e5. 34 indexed citations

Lapuente, Dennis, Pascal Irrgang, Antonia Sophia Peter, et al.. (2020). Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases. 40(4). 751–759. 23 indexed citations

Full, Florian, Michiel van Gent, Konstantin M. J. Sparrer, et al.. (2018). Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity. Nature Microbiology. 4(1). 164–176. 42 indexed citations

Frey, Benjamin, Klaus Korn, Bernhard Fleckenstein, et al.. (2016). Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain. Neuro-Oncology. 18(12). 1664–1672. 26 indexed citations

10.

Auerochs, Sabrina, Klaus Korn, & Manfred Marschall. (2011). A reporter system for Epstein-Barr virus (EBV) lytic replication: Anti-EBV activity of the broad anti-herpesviral drug artesunate. Journal of Virological Methods. 173(2). 334–339. 26 indexed citations

11.

Donhauser, Norbert, et al.. (2010). Differential Effects of P-Class Versus Other CpG Oligodeoxynucleotide Classes on the Impaired Innate Immunity of Plasmacytoid Dendritic Cells in HIV Type 1 Infection. AIDS Research and Human Retroviruses. 26(2). 161–171. 13 indexed citations

12.

Schuster, Philipp, et al.. (2009). Co‐ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology. 129(2). 234–247. 25 indexed citations

13.

Kittan, Nicolai A., Antonio Bergua, Norbert Donhauser, et al.. (2007). Impaired Plasmacytoid Dendritic Cell Innate Immune Responses in Patients with Herpes Virus-Associated Acute Retinal Necrosis. The Journal of Immunology. 179(6). 4219–4230. 31 indexed citations

14.

Fraaij, Pieter L. A., Jennifer Neubert, Alina S Bergshoeff, et al.. (2004). Safety and efficacy of a NRTI sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1 infected children.. The Pediatric Infectious Disease Journal. 9. 297–299. 1 indexed citations

15.

Wolf, Karsten D., Thomas Schnell, Wilco Keulen, et al.. (2002). The drug resistance profile of tenofovir: a story of resistance and resensitization. Antiviral Therapy. 7. 1 indexed citations

16.

Schmidt, Bárbara, Klaus Korn, Wilco Keulen, et al.. (2002). Determination of the optimal cut-offs for predicting the phenotype of nine different HIV drug-resistance algorithms. Antiviral Therapy. 7. 1 indexed citations

17.

Schmidt, Bárbara, Klaus Korn, & Hauke Walter. (2002). Technologies for measuring HIV-1 drug resistance. HIV Clinical Trials. 3(3). 227–236. 3 indexed citations

18.

Beerenwinkel, Niko, Bárbara Schmidt, Hauke Walter, et al.. (2001). Identifying drug resistance-associated patterns in HIV genotypes. MPG.PuRe (Max Planck Society). 126–130. 1 indexed citations

19.

Walter, Hauke, Bárbara Schmidt, Klaus Korn, et al.. (1999). Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. Journal of Clinical Virology. 13(1-2). 71–80. 74 indexed citations

20.

Baur, Andreas S., R. Vornhagen, Klaus Korn, et al.. (1992). Viral Culture and p24 Antigenemia of Human Immunodeficiency Virus (HIV)-Infected Individuals Correlated with Antibody Profiles Determined with Recombinant Polypeptides of All HIV-1 Open-Reading Frames. The Journal of Infectious Diseases. 165(3). 419–426. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact